189 related articles for article (PubMed ID: 2312158)
1. Tumour-induced immunity to H-Y-disparate skin grafts without concomitant priming of CTL.
Johnson LL; Hines DL
Immunology; 1990 Jan; 69(1):85-90. PubMed ID: 2312158
[TBL] [Abstract][Full Text] [Related]
2. Failure of a tumour to prime CTL specific for some of the minor H antigens it expresses but not others.
Johnson LL
Immunology; 1991 Apr; 72(4):532-6. PubMed ID: 1903766
[TBL] [Abstract][Full Text] [Related]
3. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
4. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes.
Keene JA; Forman J
J Exp Med; 1982 Mar; 155(3):768-82. PubMed ID: 6801178
[TBL] [Abstract][Full Text] [Related]
5. Prolonged Hya-disparate skin graft survival in ethanol-consuming mice: correlation with impaired delayed hypersensitivity.
Wang K; Busker-Mannie AE; Hoeft J; Vasquez K; Miller SD; Melvold RW; Waltenbaugh C
Alcohol Clin Exp Res; 2001 Oct; 25(10):1542-8. PubMed ID: 11696676
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell-defined H-Y antigen on mouse epidermal cells.
Steinmuller D; Burlingham WJ
Transplantation; 1984 Jan; 37(1):22-8. PubMed ID: 6364483
[TBL] [Abstract][Full Text] [Related]
7. Non-H-2 histocompatibility antigens encoded by Moloney-murine leukemia virus in Mov mouse strains are detectable by skin grafting and cytolytic T lymphocytes.
Wettstein PJ; Colombo MP; Jaenisch R
J Immunol; 1988 Jun; 140(12):4337-41. PubMed ID: 3286772
[TBL] [Abstract][Full Text] [Related]
8. High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice.
Isakov N; Bach FH
J Immunol; 1984 Jan; 132(1):50-6. PubMed ID: 6418804
[TBL] [Abstract][Full Text] [Related]
9. Induction of allograft tolerance to the H-Y antigen in adult C57BL/6 mice: differential effects on delayed-type hypersensitivity and cytolytic T-lymphocyte activity.
Busker AE; Miller SD; Melvold RW
Cell Immunol; 1990 Jan; 125(1):225-34. PubMed ID: 2293899
[TBL] [Abstract][Full Text] [Related]
10. T cell subsets required for in vivo and in vitro responses to single and multiple minor histocompatibility antigens.
Wettstein PJ; Korngold R
Transplantation; 1992 Aug; 54(2):296-307. PubMed ID: 1353915
[TBL] [Abstract][Full Text] [Related]
11. Adoptive immunity in immune-deficient scid/scid mice. I. Differential requirements of naive and primed lymphocytes for CD4+ T cells during rejection of minor histocompatibility antigen-disparate skin grafts.
Roopenian DC; Anderson PS
Transplantation; 1988 Dec; 46(6):899-904. PubMed ID: 2905088
[TBL] [Abstract][Full Text] [Related]
12. Distinct in vivo CD8 and CD4 T cell responses against normal and malignant tissues.
Coe D; Addey C; White M; Harwood N; Dyson J; Chai JG
Cancer Immunol Immunother; 2013 Jan; 62(1):101-12. PubMed ID: 22806093
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
Nanishi F; Nomoto K; Taniguchi K; Kubo C
Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
[TBL] [Abstract][Full Text] [Related]
14. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
Nevala WK; Paul C; Wettstein PJ
J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
[TBL] [Abstract][Full Text] [Related]
15. Skin graft rejection by beta 2-microglobulin-deficient mice.
Zijlstra M; Auchincloss H; Loring JM; Chase CM; Russell PS; Jaenisch R
J Exp Med; 1992 Apr; 175(4):885-93. PubMed ID: 1552287
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
J Immunol; 1986 Oct; 137(7):2080-8. PubMed ID: 3489752
[TBL] [Abstract][Full Text] [Related]
17. Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
de Waal LP; de Hoop J; Stukart MJ; Gleichmann H; Melvold RW; Melief CJ
J Immunol; 1983 Feb; 130(2):655-60. PubMed ID: 6401303
[TBL] [Abstract][Full Text] [Related]
18. The critical role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen.
Minagawa R; Okano S; Tomita Y; Kishihara K; Yamada H; Nomoto K; Shimada M; Maehara Y; Sugimachi K; Yoshikai Y; Nomoto K
Transplantation; 2004 Sep; 78(6):799-806. PubMed ID: 15385797
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL/6 mice following reciprocal immunization with normal versus malignant cells.
Isakov N; Segal S
Immunobiology; 1983 Dec; 165(5):485-99. PubMed ID: 6363278
[TBL] [Abstract][Full Text] [Related]
20. In vivo induction of antigen-specific transplantation tolerance to Qa1a by exposure to alloantigen in the absence of T-cell help.
Rees MA; Rosenberg AS; Munitz TI; Singer A
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2765-9. PubMed ID: 2138785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
